Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro (Q35878870)
Jump to navigation
Jump to search
scientific article published on 7 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro |
scientific article published on 7 May 2007 |
Statements
1 reference
Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro (English)
1 reference
Robert C Gallo
1 reference
Bruce Gilliam
1 reference
Anthony Devico
1 reference
Gregory B Melikyan
1 reference
Alonso Heredia
1 reference
Olga Latinovic
1 reference
Nhut Le
1 reference
Douty Bamba
1 reference
Robert R Redfield
1 reference
1 reference
1 reference
Identifiers
1 reference